Hjem › Atrieflimmer › Oklahoma
Atrieflimmer kliniske forsøg i Oklahoma
8 studier for Atrieflimmer søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFase 3
Alder 22 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT05836987A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Oklahoma Heart Hospital, Oklahoma City
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Oklahoma Heart Hospital, Oklahoma City
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- Saint Francis Hospital, Tulsa
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05963698Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
- CardioVascular Health Clinic, Oklahoma City
RekruttererObservationsstudie
22 Minutes · Alle køn · Opdateret 21. aug. 2026 · NCT07779213Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 9917, Oklahoma City
RekruttererFase 3
Alder 65 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05712200Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- OU Medical Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- Ascension St. John Medical Center, Tulsa
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. maj 2026 · NCT03907046Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 1. apr. 2026 · NCT05174052Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.